All posts

Follow Us

LinkedInInstagramX
Annual ResultsArchiveLast updated 16 November 20263 min read

Citichem India (CITICHEM) Q4 FY26's Revenue Crashes 91% as Trading Volumes Evaporate

The chemical trader's March quarter sales fell to a fraction of last year's level, though cost cuts kept the net profit margin intact.

By Vinayak Gandhi, CFA · Created 16 November 2026

Citichem India's Q4 FY26 revenue plunged 91% year-on-year to ₹4.68 crore, with profit down 71%. The collapse was driven by a sharp drop in core trading volumes, though a leaner cost structure prevented a total wipeout.

For a chemical trading firm, volume is everything. Citichem India's fourth quarter shows what happens when that volume disappears, with revenue collapsing to a fraction of its prior-year level.

Revenue fell 91% year-on-year and 54% sequentially to ₹4.68 crore. Net profit followed, dropping 71% to ₹0.32 crore. The only positive was a net profit margin that held at 6.8%, up sharply from 2.1% a year ago as costs fell even faster than sales.

Revenue & profit

Revenue (₹ Cr)

Profit (₹ Cr)

Revenue & profitQ1 FY25 1.49, Q2 FY25 1.67, Q4 FY25 52.70, Q2 FY26 10.10, Q4 FY26 4.68. Q1 FY25 0.20, Q2 FY25 0.12, Q4 FY25 1.11, Q2 FY26 0.68, Q4 FY26 0.32020406080Q1 '25Q2 '25Q4 '25Q2 '26Q4 '26
  • Revenue (₹ Cr), Q1 FY25: 1.49
  • Revenue (₹ Cr), Q2 FY25: 1.67
  • Revenue (₹ Cr), Q4 FY25: 52.70
  • Revenue (₹ Cr), Q2 FY26: 10.10
  • Revenue (₹ Cr), Q4 FY26: 4.68
  • Profit (₹ Cr), Q1 FY25: 0.20
  • Profit (₹ Cr), Q2 FY25: 0.12
  • Profit (₹ Cr), Q4 FY25: 1.11
  • Profit (₹ Cr), Q2 FY26: 0.68
  • Profit (₹ Cr), Q4 FY26: 0.32

Revenue (₹ Cr)

Revenue (₹ Cr)Q1 FY25 1.49, Q2 FY25 1.67, Q4 FY25 52.70, Q2 FY26 10.10, Q4 FY26 4.68020406080Q1 '25Q2 '25Q4 '25Q2 '26Q4 '26
  • Revenue (₹ Cr), Q1 FY25: 1.49
  • Revenue (₹ Cr), Q2 FY25: 1.67
  • Revenue (₹ Cr), Q4 FY25: 52.70
  • Revenue (₹ Cr), Q2 FY26: 10.10
  • Revenue (₹ Cr), Q4 FY26: 4.68

Profit (₹ Cr)

Profit (₹ Cr)Q1 FY25 0.20, Q2 FY25 0.12, Q4 FY25 1.11, Q2 FY26 0.68, Q4 FY26 0.3200.511.52Q1 '25Q2 '25Q4 '25Q2 '26Q4 '26
  • Profit (₹ Cr), Q1 FY25: 0.20
  • Profit (₹ Cr), Q2 FY25: 0.12
  • Profit (₹ Cr), Q4 FY25: 1.11
  • Profit (₹ Cr), Q2 FY26: 0.68
  • Profit (₹ Cr), Q4 FY26: 0.32

Net Profit Margin (%)

Net Profit Margin (%)Q1 FY25 13.4, Q2 FY25 7.2, Q4 FY25 2.1, Q2 FY26 6.7, Q4 FY26 6.80%5%10%15%20%Q1 '25Q2 '25Q4 '25Q2 '26Q4 '26
  • Net Profit Margin (%), Q1 FY25: 13.4
  • Net Profit Margin (%), Q2 FY25: 7.2
  • Net Profit Margin (%), Q4 FY25: 2.1
  • Net Profit Margin (%), Q2 FY26: 6.7
  • Net Profit Margin (%), Q4 FY26: 6.8
MetricCurrentQ4 FY26Same quarter LYQ4 FY25
Revenue (₹ Cr)
4.68YoY -91%
52.70
Profit (₹ Cr)
0.32YoY -71%
1.11
Net Profit Margin (%)
6.8YoY +224%
2.1

Why the Top Line Evaporated

The revenue crash stems from a steep decline in core chemical trading. According to a scanx.trade report, revenue from operations nearly halved for the full year due to lower trading volumes. This suggests the Q4 plunge is not an anomaly but an acceleration of a weakening trend.

A key income source also vanished. Other operating income, which had included a large one-time write-back of creditor balances in FY25, fell over 95% sequentially. This removed a significant non-core prop that had previously flattered total revenue.

A Balance Sheet in Transition

Despite the operational weakness, the company used the period to strengthen its financial position. A report from mcapital.in notes Citichem used strong operating cash flow to repay nearly all its short-term borrowings, cutting debt from ₹7.72 crore in March 2026 to near zero by September.

Live Chart

· CITICHEM

(BSE)

ISIN: INE0A8401016

This deleveraging is a clear positive. However, it came alongside a worrying metric: trade receivables remained stubbornly high at over ₹30 crore. Against a shrunken revenue base, this implies severely stretched cash conversion cycles.

The Outlook: More Contraction Ahead

The immediate future points to continued pressure. For the full year FY26, revenue fell 73% to ₹14.78 crore, while profit declined a more modest 19% to ₹1.00 crore. The five-year picture is one of shrinking sales but rising profits, highlighting a shift towards a smaller, more margin-focused operation.

Data for the subsequent half-year ended September 2026, cited by MarketPing, shows the trend persisting. Revenue from operations remained weak, indicating the trading recovery is not yet in sight. The broader chemical sector is in a tentative recovery, but traders without proprietary products may be the last to benefit.

Key Points

  • Quarterly revenue collapsed 91% year-on-year, driven by a severe drop in chemical trading volumes and the absence of prior-year one-time income.
  • Aggressive cost reduction allowed the net profit margin to expand to 6.8%, preventing a complete bottom-line wipeout.
  • The company significantly strengthened its balance sheet by using operating cash to repay almost all short-term debt.
  • High receivables against a diminished revenue base signal ongoing working capital stress and poor cash conversion.

Hexa Perspective

This quarter reveals a business in retreat, surviving on cost control rather than growth. The near-total debt repayment is a prudent step that reduces financial risk, but it does not address the core issue of evaporating demand.

The stretched receivables are a major concern, tying up capital in a business with minimal sales. Investors are left weighing a cleaner balance sheet against a top line that has not yet found a floor. Until trading volumes show a sustained recovery, the story remains one of containment, not turnaround.

Share or follow HexaWealth

Also read

Want this applied to your portfolio?

Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.

Citichem India (CITICHEM) Q4 FY26 results, revenue and profits.

Frequently asked questions

What were Citichem India's Q4 FY26 results?
Citichem India reported Q4 FY26 revenue of ₹4.68 crore, a 91% year-on-year decline. Net profit for the quarter was ₹0.32 crore, down 71% from the same period last year. The net profit margin, however, improved to 6.8% from 2.1% in Q4 FY25.
Why did Citichem India's Q4 FY26 revenue collapse by 91%?
Citichem's revenue collapsed due to a sharp decline in its core chemical trading volumes, as reported by scanx.trade. Additionally, other operating income, which included a large one-time write-back in the prior year, fell by over 95% quarter-on-quarter, removing a significant non-core revenue source.
How did Citichem India's net profit margin improve despite the revenue crash?
Citichem's net profit margin improved to 6.8% in Q4 FY26 because total expenses fell even faster than revenue, declining 92% year-on-year. This aggressive cost reduction, particularly in purchase costs, prevented a complete erosion of profitability despite the massive sales drop.
What is the state of Citichem India's debt and working capital?
Citichem India significantly improved its debt position, using operating cash to repay nearly all short-term borrowings, as per mcapital.in. However, working capital remains stressed with trade receivables still high at over ₹30 crore, leading to a severely stretched cash conversion cycle.
What is Citichem India's full-year FY26 performance?
For the full year ended March 2026, Citichem India's revenue was ₹14.78 crore, down 73% from FY25. Net profit for the year was ₹1.00 crore, an 18.6% decline. This shows a full year of severe revenue contraction with profits declining at a slower rate.
What is the outlook for Citichem India after Q4 FY26?
The outlook suggests continued pressure. Data for the half-year ended September 2026 shows persistently weak revenue from operations. The company appears to be operating as a much smaller entity, with recovery contingent on a rebound in chemical trading demand that is not yet evident.
Did Citichem India's Q4 FY26 results beat analyst estimates?
Available research does not cite a specific analyst consensus or estimates for Citichem India's Q4 FY26 results. The company is a small-cap SME stock with limited brokerage coverage, making a clear beat-or-miss comparison difficult to establish.
How did Citichem India's stock price react to the Q4 FY26 results?
Specific intraday reaction data is not provided. However, broader stock performance data from DataCedar shows the stock returned -38.6% over the year to November 2026, reflecting the challenging operational environment the company has faced.
Citichem India Q4 FY26 results August 2026
Citichem India announced its Q4 FY26 (March quarter) results on May 30, 2026, not in August. The results showed revenue of ₹4.68 crore and a net profit of ₹0.32 crore for the quarter ended March 2026.
Citichem India net profit
Citichem India's net profit for Q4 FY26 was ₹0.32 crore. For the full financial year FY26, the company reported a net profit of ₹1.00 crore, which represents an 18.6% decline from the ₹1.23 crore profit reported in FY25.